Mario Taffurelli

Mario Taffurelli

Auto-generated profile, based on publicly available information

Mario Taffurelli

Breast Unit, Department of Woman and Child, IRCCS Azienda Ospedaliero-Universitaria of Bologna, 40138 Bologna, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

28 March 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
ASAlessandro Sanguinetti
Alessandro Sanguinetti
DSDonatella Santini
Donatella Santini
MBMASSIMILIANO BONAFE'
MASSIMILIANO BONAFE'
MTMario Taffurelli
Mario Taffurelli
NANicola Avenia
Nicola Avenia
Greater than 50,000 new cases of breast cancer cases were diagnosed in Italy during 2013, with nearly 15,000 women succumbing to the disease. These epidemiological statistics highlight the overwhelming clinical dilemma of breast cancer and emphasize the need for novel therapeutic targets and prevention strategies. Countless studies in the fields of mammary gland development and breast cancer have led to an appreciation of a breast tumor microenvironment that actively contributes to the heterogeneous nature of breast cancer. The current review will focus on the impact of IL-6 and in the breast tumor microenvironment. Excessive IL-6 has been demonstrated in primary breast tumors and breast cancer patient sera and is associated with poor clinical outcomes in breast cancer. These clinical associations are corroborated by emerging preclinical data revealing that IL-6 is a potent growth factor and promotes an epithelial-mesenchyme (EMT) phenotype in breast cancer cells to indicate that IL-6 in the breast tumor microenvironment is clinically relevant. High serum levels of interleukin-6 correlate with poor outcome in breast cancer patients. However, few data are yet available on the relationship between IL-6 and stem/progenitor cells, which may fuel the genesis of breast cancer in vivo. Mammospheres (MS) from node invasive breast carcinoma tissues express IL-6 mRNA at higher levels than MS from matched non-neoplastic mammary glands. IL-6 mRNA is detectable only in basal-like breast carcinoma tissues; our results reveal that IL-6 triggers a Notch-3-dependent upregulation of the Notch ligand Jagged-1, whose interaction with Notch-3 promotes the growth of MS and Michigan Cancer Foundation-7 (MCF-7)-derived spheroids. IL-6 induces a Notch-3-dependent upregulation of the carbonic anhydrase IX gene and promotes a hypoxia-resistant/invasive phenotype in MCF-7 cells and MS. In conclusion, our data support the hypothesis that IL-6 induces malignant features in Notch-3-expressing, stem/progenitor cells from human ductal breast carcinoma and normal mammary gland.

10 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
EPEleonora Porcu
Eleonora Porcu
LCLinda Cipriani
Linda Cipriani
MDMaria Dirodi
Maria Dirodi
Pierandrea De IacoPierandrea De Iaco
Pierandrea De Iaco
Anna PerroneAnna Perrone
Anna Perrone
GDGiuseppe Damiano
Giuseppe Damiano
The preservation of fertility in cancer patients is a crucial aspect of modern reproductive medicine. Amenorrhea and infertility often occur after cancer therapy, worsening the quality of life. Cryopreservation of oocytes in young cancer patients is a therapeutic option for preserving fertility. A prospective study was conducted on 508 cancer patients who underwent oocyte cryopreservation to preserve fertility between 1996 and 2021 including the COVID-19 pandemic period. Patients underwent ovarian stimulation, followed by egg retrieval, and oocytes were cryopreserved by slow freezing or vitrification. Sixty-four thawing/warming cycles were performed. Survival, fertilization, pregnancy, and birth rate over the thawing/warming cycles were obtained. The data were compared with those from a group of 1042 nononcological patients who cryopreserved supernumerary oocytes. An average of 8.8 ± 6.9 oocytes were retrieved per cycle, and 6.1 ± 4.2 oocytes were cryopreserved. With their own stored oocytes, 44 patients returned to attempt pregnancy. From a total of 194 thawed/warmed oocytes, 157 survived (80%). In total, 100 embryos were transferred in 57 transfer/cycles, and 18 pregnancies were achieved. The pregnancy rate per transfer and pregnancy rate per patient were 31% and 41%, respectively. No statistically significant differences were observed between oncological patients and nononcological patients. A total of 15 babies were born from oncological patients. Children born showed normal growth and development. One minor malformation was detected.


8 August 2008 in BMC Cancer
Verified
Journal Article
Open access
PDF file
RSRossella Solmi
Rossella Solmi
MLMattia Lauriola
Mattia Lauriola
MFMirko Francesconi
Mirko Francesconi
DMDésirée Martini
Désirée Martini
MVManuela Voltattorni
Manuela Voltattorni
PSPierluigi Strippoli
Pierluigi Strippoli
EGFR is frequently overexpressed in colon cancer. We characterized HT-29 and Caco-2, human colon cancer cell lines, untreated and treated with cetuximab or gefitinib alone and in combination with EGF.

8 September 2016 in Surgery
Verified
Journal Article
Closed access
PDF file
MTMario Taffurelli
Mario Taffurelli
APAlice Pellegrini
Alice Pellegrini
DSDonatella Santini
Donatella Santini
SZSimone Zanotti
Simone Zanotti
DSDomenico Di Simone
Domenico Di Simone
MSMargherita Serra
Margherita Serra